Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Bulletin of Experimental Biology and Medicine
Metadata
Title
Olivomycin Induces Tumor Cell Apoptosis and Suppresses p53-Induced Transcription
Authors
V. S. Simonova
A. V. Samusenko
N. A. Filippova
A. N. Tevyashova
L. S. Lyniv
G. I. Kulik
V. F. Chekhun
A. A. Shtil’
Publication date
01-04-2005
Publisher
Kluwer Academic Publishers-Consultants Bureau
Published in
Bulletin of Experimental Biology and Medicine / Issue 4/2005
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-005-0321-3

Other articles of this Issue 4/2005

Bulletin of Experimental Biology and Medicine 4/2005 Go to the issue

OriginalPaper

Mechanisms of the Effect of 1,1-Dimethyl-3-Hydroxybutyl Phosphonic Acid Derivatives on Synaptic Transmission in Neuromuscular Junction

Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

A Method for Cellular Stimulation of Thyroid Transplant for Correction of Thyroid System Function

OriginalPaper

Analgesic Activity of 5-HT3 Receptor Antagonists

OriginalPaper

Allergic and Immunotoxic Effects of Calcium Ketopantoyl Aminobutyrate

OriginalPaper

The Course of Experimental Myocardial Infarction under Conditions of Suppressed and Enhanced NO Synthesis

Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

In Vivo and in Vitro Proliferative and Differentiation Activity of Human Embryonic Retinal Cells
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits